Skip to main content
. 2021 Nov 10;42(4):NP230–NP241. doi: 10.1093/asj/sjab387

Table 3.

Treatment-Associated AEs and Incidence

Treatment-associated AEs HA filling plus mesotherapy combined treatment group, n (%) BTX-A treatment group, n (%) P value
Lumps 2 (8)
Erythema 25 (100) 22 (95.7) 0.479
Topical edema and swelling 25 (100) 2 (8.7) 0.000
Ecchymosis 14 (56) 7 (30.4) 0.074
Tyndall effect 2 (8)
Trachyphonia 1 (4.3)
Rashes and itchiness 3 (12)

AE, adverse event; BTX-A, botulinum toxin A; HA, hyaluronic acid.